Skip to main content
. 2022 Feb 15;21:15330338221077803. doi: 10.1177/15330338221077803

Figure 3.

Figure 3.

SLC16A1-AS1 acts as a sponge of miR-143-3p. (A, B) The localization of SLC16A1-AS1 was examined in 786-O and Caki-1 cells. (C) The putative binding site of miR-143-3p on SLC16A1-AS1. (D) The expression level of miR-143-3p in RCC cells was determined by qRT–PCR. (E) MS2-based RIP assay in RCC cells. (F) The expression level of miR-143-3p in RCC cells after transfection with si-SLC16A1-AS1. *p<.05, **p<.01 compared with the NC group.

Abbreviations: miR-143-3p, microRNA-143-3p; RCC, renal cell carcinoma; qRT–PCR, quantitative reverse transcription–polymerase chain reaction; RIP, RNA-binding protein immunoprecipitation; NC, negative control.